☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
PharmaShots Weekly Snapshots (February 14-18, 2022)
February 18, 2022
BMS Reports the US FDA Acceptance of sBLA for Priority Review of Breyanzi (lisocabtagene maraleucel) as a 2L Treatment for Large B...
February 18, 2022
Regeneron and Sanofi Stop P-III (CUPID STUDY B) Trial of Dupixent (dupilumab) for the Treatment of Chronic Spontaneous Urticaria
February 18, 2022
BMS Presents Interim Results of Zeposia (ozanimod) in P-III (True North) OLE Study for the Treatment of Active Ulcerative Colitis...
February 18, 2022
Novavax Receives the Health Canada Marketing Authorization for Nuvaxovid (NVX-CoV2373) to Treat COVID-19
February 18, 2022
UCB’s Bimzelx (bimekizumab) Receives Health Canada’s Approval for the Treatment of Plaque Psoriasis
February 18, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions